Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.
about
Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoeaClinical implications of enteroadherent Escherichia coliCrystal structure of enterotoxigenic Escherichia coli colonization factor CS6 reveals a novel type of functional assemblyTowards Rational Design of a Toxoid Vaccine against the Heat-Stable Toxin of Escherichia coliToxicity and immunogenicity of Enterotoxigenic Escherichia coli heat-labile and heat-stable toxoid fusion 3xSTa(A14Q)-LT(S63K/R192G/L211A) in a murine model.Sulfatide recognition by colonization factor antigen CS6 from enterotoxigenic Escherichia coli.Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccineFrom cholera to enterotoxigenic Escherichia coli (ETEC) vaccine developmentNovel antigens for enterotoxigenic Escherichia coli vaccinesRecent advances in understanding enteric pathogenic Escherichia coli.Vaccines against enterotoxigenic Escherichia coli.Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.Expert review of the evidence base for prevention of travelers' diarrhea.Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity.Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phasVaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea.Antibodies derived from an enterotoxigenic Escherichia coli (ETEC) adhesin tip MEFA (multiepitope fusion antigen) against adherence of nine ETEC adhesins: CFA/I, CS1, CS2, CS3, CS4, CS5, CS6, CS21 and EtpA.Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IV.Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design.Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults.Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.Recent progress toward an enterotoxigenic Escherichia coli vaccine.Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.Vaccination for the expatriate and long-term traveler.Development of a new tuberculosis vaccine: is there value in the mucosal approach?Enterotoxigenic Escherichia coli heat-stable toxin and heat-labile toxin toxoid fusion 3xSTaN12S-dmLT induces neutralizing anti-STa antibodies in subcutaneously immunized mice.Toxins and virulence factors of enterotoxigenic Escherichia coli associated with strains isolated from indigenous children and international visitors to a rural community in Guatemala.Etiology of travellers' diarrhea.Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas.Enterotoxigenic Escherichia coli multilocus sequence types in Guatemala and Mexico.Identification and characterization of the novel colonization factor CS30 based on whole genome sequencing in enterotoxigenic Escherichia coli (ETEC).Enterotoxigenic Escherichia coli (ETEC) adhesin-toxoid MEFA (multiepitope fusion antigen) CFA/I/II/IV-3xSTaN12S-mnLTG192G/L211A derived antibodies inhibit adherence of seven adhesins (CFA/I, CFA/II & CFA/IV), neutralize enterotoxicity of both toxinsNeutralizing Anti-Heat-Stable Toxin (STa) Antibodies Derived from Enterotoxigenic Escherichia coli Toxoid Fusions with STa Proteins Containing N12S, L9A/N12S, or N12S/A14T Mutations Show Little Cross-Reactivity with Guanylin or Uroguanylin.Co-administered Tag-Less Toxoid Fusion 3xSTaN12S-mnLTR192G/L211A and CFA/I/II/IV MEFA (Multiepitope Fusion Antigen) Induce Neutralizing Antibodies to 7 Adhesins (CFA/I, CS1-CS6) and Both Enterotoxins (LT, STa) of Enterotoxigenic Escherichia coli (ETComparison of stool collection and storage on Whatman FTA Elute cards versus frozen stool for enteropathogen detection using the TaqMan Array Card PCR assay
P2860
Q24201328-D015E430-9838-43E3-822D-6FF71E2266E0Q26865925-6C5D3379-F5CD-4422-8741-E7423E093BECQ27682738-7C9A18A2-FC77-4757-BAF2-85A2D7B454E7Q30277331-520379DD-B63D-4F45-A365-A8CFA8C59EABQ30416787-A731B58E-A935-4188-8A21-C2575D620410Q33412400-DA723C73-87DF-4FDC-A186-26E54A361267Q33928456-C3DFF1BB-7F41-4F7E-9FF0-E852ED8F47C6Q34171594-F4A1D29A-E102-462D-A061-BA14CC4EC505Q34349166-A8E8E95B-855A-40E9-9DF8-8CD71BAB5443Q34375210-39D99EE3-8934-4C44-9706-67D36C6A2172Q34594874-958D8992-50F2-4D5C-AC71-366A2F864408Q34787413-0A76AAC4-45B9-4E9E-A042-101DC9390F52Q34987670-8F07A6F6-F2FC-43BB-A5E5-5A5BE92D46A4Q35213355-710E9C75-E0F8-4BDA-A35B-614370FEFB87Q35271174-6BACC845-010C-4FB5-BF7C-AAE2A4F848A2Q35598235-F7374194-335D-49BA-94AA-7D86F13296AEQ35887055-34163CC5-5097-422F-8DC2-8B773B355711Q35998767-A05D80CC-2214-4CF9-94E9-58881F1E3DB9Q37057975-5725F2CC-0560-48C9-B092-30302CB0DE06Q37545078-9F1B09FB-D5BA-484F-9B18-7A9945BB2CFFQ37581984-E8F81629-523E-4112-B4A0-9B088C0842A3Q37721929-E64C27E2-F544-41CE-96A7-AA98A5EBA956Q37986492-4AF8EE30-73AD-4FF7-9334-EBA27EAD860EQ38006998-FD8791D3-08A3-4BFE-B721-C9D2877F2C51Q38032878-B069735C-EAB6-4903-BC76-5E870023CE5CQ38208436-1FCE5AAA-CA23-455D-8E3C-3F6E5925E44AQ38262258-39AE46CC-B8D2-4194-9C8E-523CC1B6C44FQ39218689-E49EB451-13C8-4E5C-B5C9-516BD7AC7241Q40148554-4612D34F-6F98-4275-994F-762D6310DDFCQ40207460-CA92D9D5-A43F-4EC6-9B0C-801BBD87C99DQ40375701-35D324B9-C6CE-4B71-A515-0EE86A115647Q40682233-077175DA-97AF-45DC-B51B-593F8C1C84CEQ42286156-8C9414BD-023E-4C32-ADFC-9529F09549D0Q47269501-E3047FF8-821D-4DFA-A238-3C9B5E4C7BEEQ47592750-4D8CA9A5-284E-448B-ACBD-FB57CEBA4E20Q55315300-DB5B584F-540B-46FC-BBF7-C20DDC09AAB6Q57929499-E42AD33A-6AD1-4DF2-9D12-8AE34E795385
P2860
Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Randomised, double-blind, safe ...... llers to Guatemala and Mexico.
@en
Randomised, double-blind, safe ...... llers to Guatemala and Mexico.
@nl
type
label
Randomised, double-blind, safe ...... llers to Guatemala and Mexico.
@en
Randomised, double-blind, safe ...... llers to Guatemala and Mexico.
@nl
prefLabel
Randomised, double-blind, safe ...... llers to Guatemala and Mexico.
@en
Randomised, double-blind, safe ...... llers to Guatemala and Mexico.
@nl
P2093
P1433
P1476
Randomised, double-blind, safe ...... llers to Guatemala and Mexico.
@en
P2093
Anders Kärnell
August L Bourgeois
Björn Gustafsson
Domingo Sanchez Francia
Iréne Nyquist
Janet Shimko
Olga Torres
P304
P356
10.1016/J.VACCINE.2007.03.034
P407
P577
2007-04-04T00:00:00Z